Baudax Bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
24.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-21.20
|
-98.80
|
-77.60
|
-366.04%
|
|
2022-06-30
|
-50.80
|
-42.00
|
8.80
|
17.32%
|
|
2022-03-31
|
-74.00
|
-126.80
|
-52.80
|
-71.35%
|
|
2021-12-31
|
59.00
|
401.20
|
342.20
|
580.00%
|
|
2021-09-30
|
-217.00
|
-280.00
|
-63.00
|
-29.03%
|
|
2021-06-30
|
-280.00
|
-280.00
|
0.00
|
0.00%
|
|
2021-03-31
|
-270.67
|
-378.00
|
-107.33
|
-39.65%
|
|
2020-12-31
|
-849.33
|
-770.00
|
79.33
|
9.34%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-267.60
|
|
2021-12-31
|
-536.80
|
|
2020-12-31
|
-949.55
|
|
2019-12-31
|
-30.06
|